Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP946673.RApyhCNI_wPb9tcwnppqiL6PfAUOOjXYeukWaEG3zwTqQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP946673.RApyhCNI_wPb9tcwnppqiL6PfAUOOjXYeukWaEG3zwTqQ130_assertion type Assertion NP946673.RApyhCNI_wPb9tcwnppqiL6PfAUOOjXYeukWaEG3zwTqQ130_head.
- NP946673.RApyhCNI_wPb9tcwnppqiL6PfAUOOjXYeukWaEG3zwTqQ130_assertion description "[Standard chemotherapy for adrenocortical cancer currently is under evaluation in the context of the recently completed FIRM-ACT evaluating the combination of mitotane with either streptozocin or etoposide, cisplatin, and doxorubicin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946673.RApyhCNI_wPb9tcwnppqiL6PfAUOOjXYeukWaEG3zwTqQ130_provenance.
- NP946673.RApyhCNI_wPb9tcwnppqiL6PfAUOOjXYeukWaEG3zwTqQ130_assertion evidence source_evidence_literature NP946673.RApyhCNI_wPb9tcwnppqiL6PfAUOOjXYeukWaEG3zwTqQ130_provenance.
- NP946673.RApyhCNI_wPb9tcwnppqiL6PfAUOOjXYeukWaEG3zwTqQ130_assertion SIO_000772 22170383 NP946673.RApyhCNI_wPb9tcwnppqiL6PfAUOOjXYeukWaEG3zwTqQ130_provenance.
- NP946673.RApyhCNI_wPb9tcwnppqiL6PfAUOOjXYeukWaEG3zwTqQ130_assertion wasDerivedFrom befree-2016 NP946673.RApyhCNI_wPb9tcwnppqiL6PfAUOOjXYeukWaEG3zwTqQ130_provenance.
- NP946673.RApyhCNI_wPb9tcwnppqiL6PfAUOOjXYeukWaEG3zwTqQ130_assertion wasGeneratedBy ECO_0000203 NP946673.RApyhCNI_wPb9tcwnppqiL6PfAUOOjXYeukWaEG3zwTqQ130_provenance.